What is the appropriate emergency management for a patient who ingested Ratol (yellow‑phosphorus) rodenticide within one hour, with a protected airway?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Management of Ratol (Yellow Phosphorus) Poisoning

For a patient presenting within one hour of Ratol ingestion with a protected airway, immediately contact poison control, perform gastric decontamination with activated charcoal (1-2 g/kg), initiate aggressive supportive care, and admit for monitoring regardless of initial symptoms due to the characteristic delayed toxidrome that emerges 18-72 hours post-exposure. 1, 2

Immediate Actions (First Hour)

Poison Control Consultation

  • Contact the national poison control center immediately (1-800-222-1222 in the United States) for real-time expert guidance on yellow phosphorus management. 3, 4
  • Do not delay supportive care while awaiting poison control advice. 3

Gastrointestinal Decontamination

  • Administer activated charcoal at 1-2 g/kg body weight since the patient presents within 1 hour and has a protected airway. 3, 1
  • Gastric lavage is not recommended for yellow phosphorus poisoning due to lack of proven benefit and significant risks including aspiration, dysrhythmias, and esophageal perforation. 3, 4
  • Do not induce emesis with ipecac—it increases aspiration risk and is no longer recommended. 3, 5

Supportive Care Foundation

  • Maintain continuous hemodynamic monitoring (blood pressure, heart rate, oxygen saturation) throughout the observation period. 3, 6
  • Establish intravenous access for fluid resuscitation and medication administration. 3, 6
  • Ensure airway protection remains secure, as yellow phosphorus can cause delayed central nervous system depression. 6, 1

Critical Clinical Awareness: The Delayed Toxidrome

Yellow phosphorus poisoning characteristically presents with a conspicuous absence of symptoms during the first 24 hours, followed by a symptomless phase with stable vitals, then sudden deterioration 18-72 hours post-exposure. 2, 7

  • 72.73% of patients manifest toxicity after a lag period of 24-36 hours (range 18-72 hours). 2
  • Never discharge a patient based on initial clinical stability—the case fatality demonstrates patients can appear well on day 2, then develop fatal multi-organ failure by days 3-5. 8, 2
  • The mean time to death is 4.22 days since exposure (range 2-8 days), with 77.78% dying from fulminant hepatic failure. 2

Hospital Admission Criteria

All patients with yellow phosphorus ingestion require hospital admission for a minimum 72-hour observation period, regardless of initial symptom status. 1, 2

  • Survival rates are significantly higher (97.87% vs 84.62%) when gastric decontamination is instituted within 2 hours of exposure. 2
  • Time to resuscitation shows significant correlation with mortality. 2

Monitoring Protocol (First 72 Hours)

Clinical Surveillance

  • Monitor for dominant clinical manifestations including: 2, 7
    • Abdominal pain (52.53% of cases)
    • Jaundice (22.21%)
    • Coagulopathy (15.15%)
    • Hepatic encephalopathy (10.10%)
    • Shock (10.10%)
    • Acute kidney injury (7.08%)
    • Multi-organ failure (17.17%)

Laboratory Monitoring

  • Obtain baseline and serial measurements every 12-24 hours: 1, 2
    • Liver function tests (AST, ALT, bilirubin)
    • Coagulation studies (PT/INR, aPTT)
    • Renal function (creatinine, BUN)
    • Arterial blood gas (for metabolic acidosis)
    • Complete blood count

Poor Prognostic Indicators

The following predict bad outcomes and potential need for liver transplantation: 1, 2, 7

  • Delayed resuscitation (>2 hours)
  • Jaundice development
  • Hepatic encephalopathy
  • AST and ALT elevation >1000 IU/L
  • Metabolic acidosis
  • Refractory shock
  • Coagulopathy (PT/INR prolongation)

Intensive Care Management

Hepatic Failure Management

  • Prepare for potential fulminant hepatic failure—the most common cause of death (77.78% of fatalities). 2, 7
  • Consider early consultation with liver transplant center if AST/ALT >1000 IU/L or coagulopathy develops. 1, 2
  • Therapeutic plasma exchange may be considered in severe cases per expert consultation. 1

Supportive Interventions

  • Treat hyperthermia aggressively with external cooling if present. 6
  • Manage seizures with benzodiazepines if they occur. 6
  • Provide vasopressor support (preferably norepinephrine) for refractory hypotension after adequate fluid resuscitation. 6
  • Initiate renal replacement therapy if acute kidney injury develops. 1

Critical Pitfalls to Avoid

  • Do not discharge patients based on initial clinical stability or after a symptom-free period—the characteristic delayed toxidrome makes early discharge potentially fatal. 8, 2
  • Do not delay airway management while attempting decontamination procedures. 3, 6
  • Do not assume single-agent ingestion—mixed rodenticide formulations (yellow phosphorus + zinc phosphide) occur in 24% of cases. 2
  • Do not administer any oral agents unless specifically directed by poison control specialists. 4
  • Do not provide supplemental oxygen unnecessarily if the patient maintains adequate saturation. 3

Discharge Criteria

Discharge is only appropriate after 72 hours of observation with: 1, 2

  • No clinical manifestations of toxicity
  • Normal or stable liver function tests
  • Normal coagulation studies
  • No metabolic acidosis
  • Stable renal function
  • Clear plan for outpatient follow-up within 48 hours

References

Research

Rodenticide Poisoning: Critical Appraisal of Patients at a Tertiary Care Center.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2020

Guideline

Management of Paradichlorobenzene Ingestion – Evidence‑Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Gastric Lavage for Paraquat Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evidence‑Based Management of 2,4‑D Amine Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the treatment for a patient with deliberate self-harm involving yellow phosphorus rodenticide?
What is the emergency management and treatment for a patient who has ingested Ratol (yellow‑phosphorus) rodenticide?
What is the recommended approach to sedation in a patient with yellow phosphorus poisoning who is not on mechanical ventilation?
What is the management of rodenticide (rat poison) poisoning in India?
What is the management approach for rodenticide poisoning in an Intensive Care Unit (ICU) setting in India?
What is the appropriate treatment plan for a patient with type 2 diabetes and a hemoglobin A1c of 10.9%?
How should I manage a female outpatient with iron‑deficiency anemia, elevated LDL cholesterol, pre‑diabetic fasting glucose, and an eGFR of 65 mL/min/1.73 m²?
In an older adult with progressive cognitive decline and no focal neurologic deficits, should the initial brain MRI for dementia evaluation be performed with gadolinium contrast or without contrast?
How is the ABCD2 (Age, Blood Pressure, Clinical Features, Duration, Diabetes mellitus) score calculated and applied to estimate short‑term stroke risk after a transient ischemic attack?
How should I evaluate and manage urinary symptoms (stress leakage, incomplete emptying, frequency, urgency, recurrent UTIs) caused by a cystocele in a postmenopausal woman?
What are the dosing, administration timing, contraindications, adverse effects, alternatives, and storage recommendations for pegfilgrastim in adults receiving myelosuppressive chemotherapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.